31 January 2023, Strasbourg, France, and London, United Kingdom -- SNOMED International and the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, have signed an agreement governing the creation, maintenance and distribution of a map between both organisations’ terminologies. The agreement came into effect in September 2022.
The agreement resulted from the need identified by SNOMED International’s Drug Extension User Support Group to align EDQM Standard Terms and SNOMED CT dose forms to serve specific use cases. It will focus on putting in place mechanisms for the release, maintenance and updating of the mapping between the lists of controlled terms in the EDQM Standard Terms database and the equivalent lists in SNOMED CT.
Both organisations will review the conditions of the agreement every five years. They will also ensure that the quality of the map being created under the agreement meets the needs of stakeholders, and will put in place plans to distribute, maintain and update it. Additionally, any new content that is needed to create the map will be included in regular SNOMED CT International Edition releases and made available by both parties. As the work develops, both organisations may also propose future collaborative activities based on emerging requirements in the European Union or elsewhere.